Article
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Shares of Marriott Vacations Worldwide Corp (NYSE:VAC) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY26 adjusted EPS guidance above estimates.

Marriott Vacations posted adjusted EPS of $1.86, beating market estimates of $1.57. The company's quarterly sales came in at $1.323 billion versus estimates of $1.294 billion.

Marriott Vacations shares jumped 12.7% to $65.34 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Healthcare Triangle Inc (NASDAQ:HCTI) gained 58.2% to $9.19 in pre-market trading fter the company announced that its subsidiary, QuantumNexis Malaysia, entered into a strategic partnership with TNG Digital.
  • Profusa Inc (NASDAQ:PFSA) gained 57.1% to $1.98 in pre-market trading. The company recently announced it received several purchase orders for the Lumee tissue oxygen monitoring system and raised its FY26 revenue guidance.
  • Curanex Pharmaceuticals Inc (NASDAQ:CURX) gained 42.1% to $0.45 in pre-market trading. The New York-based pharmaceutical company announced on Wednesday the completion of a Good Manufacturing Practice (GMP)-compliant pilot-scale batch of its lead botanical drug candidate, Phyto-N.
  • MDJM Ltd (NASDAQ:UOKA) gained 39.8% to $0.27 in pre-market trading after surging 24% on Wednesday.
  • Nutanix Inc (NASDAQ:NTNX) rose 21% to $46.50 in pre-market trading after the company reported better-than-expected second-quarter sales results. Also, the company signed a multi-year agreement with AMD to develop an open, full-stack AI infrastructure platform to power agenic AI applications.
  • Sezzle Inc (NASDAQ:SEZL) gained 15.8% to $72.48 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its FY26 adjusted EPS guidance above estimates. Also, the company issued FY26 sales guidance above estimates.
  • Red Robin Gourmet Burgers Inc (NASDAQ:RRGB) rose 14.4% to $4.15 in pre-market trading after the company reported better-than-expected quarterly financial results.
  • BTQ Technologies Corp (NASDAQ:BTQ) gained 13.2% to $3.69 in pre-market trading after jumping 29% on Wednesday.
  • IONQ Inc (NYSE:IONQ) surged 13.2% to $38.04 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY26 sales guidance above estimates.

Losers

  • Matinas BioPharma Holdings Inc (NYSE:MTNB) fell 24.1% to $0.46 in pre-market trading.
  • Procept Biorobotics Corp (NASDAQ:PRCT) shares dipped 23.5% to $21.30 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and cut its FY26 guidance.
  • C3.ai Inc (NYSE:AI) dipped 23.5% to $7.89 in pre-market trading after the company reported worse-than-expected third-quarter financial results.
  • Array Technologies Inc (NASDAQ:ARRY) fell 23.5% to $8.40 in pre-market trading after the company reported fourth-quarter financial results and issued fY26 adjusted EPS guidance below estimates.
  • Energy Recovery Inc (NASDAQ:ERII) fell 19.2% to $13.02 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and issued FY26 guidance below estimates.
  • Trade Desk Inc (NASDAQ:TTD) dipped 16.6% to $20.99 in pre-market trading after the company reported fourth-quarter financial results and issued first-quarter revenue guidance below estimates.
  • Goodrx Holdings Inc (NASDAQ:GDRX) tumbled 14.7% to $2.09 in pre-market trading after the company reported fourth-quarter financial results and issued FY26 sales guidance below estimates.
  • Innovex International Inc (NYSE:INVX) fell 11.8% to $25.80 in pre-market trading after the company announced pricing of underwritten offering of 5,750,000 shares of common stock by selling stockholders.
  • Vir Biotechnology Inc (NASDAQ:VIR) declined 10.8% to $8.92 in pre-market trading as the company announced pricing of public offering of common stock.
  • Larimar Therapeutics Inc (NASDAQ:LRMR) fell 9.6% to $5.38 in pre-market trading as the company announced pricing of upsized $100 million underwritten public offering.

Photo via Shutterstock

Comments
  • No comments yet. Be the first to comment!